(PharmaNewsWire.Com, September 29, 2017 ) The Latin America mycoplasma testing market was worth USD 65.12 Million in 2016 and is estimated to be growing at a CAGR of 12.3%, to reach USD 116.3 Million by 2021. The species of Mycoplasma are the smallest living organisms and are peculiar among prokaryotes due to the absence of cell wall. It is also the reason that they are not detected anti-microbial agents and for the absence of reaction to Gram stain.
They only have the minimum required components or organelles for them to replicate. Mycoplasma are largely responsible for the contamination of cell cultures in laboratories. The source of infection can be untested infected cells and contaminated individuals who enter the laboratory. Testing for the presence of newly brought cell lines is essential before conducting experiments. There are variety of testing equipment and methods available in the market.
With the lot of research being conducted on life sciences all over the world, the demand for mycoplasma testing is increasing and is expected to grow in the forecast period. Increasing funding for research activities in cell culture and increased expenditure on healthcare by government are also expected to drive the mycoplasma testing market. Sky-high costs associated with the mycoplasma testing and stringent government guidelines are hindering the market growth in this region.
Market Segmentation
Product Kits & Reagent o PCR Assays o Nucleic Acid Detection Kits o Elimination Kits & Reagents o Stains o Standards & Controls o Other Kits & Reagents Instruments Services Y-o-Y Growth Analysis, By Product Market Attractiveness Analysis, By Product Market Share Analysis, By Product
Technique PCR ELSA Direct Assays Indirect Assays Microbial culture techniques Enzymatic Methods DNA Staining Y-o-Y Growth Analysis, By Technique Market Attractiveness Analysis, By Technique Market Share Analysis, By Technique
Application Cell Line Testing Virus Testing End-Of-Production Cell Testing Other Applications Y-o-Y Growth Analysis, By Application Market Attractiveness Analysis, By Application Market Share Analysis, By Application
End User Pharmaceutical Companies Contract Research Organizations Academic Research Institutes Cell Banks Y-o-Y Growth Analysis, By End User Market Attractiveness Analysis, By End User Market Share Analysis, By End User
The mycoplasma testing market of Latin America is geographically segmented into Brazil, Argentina, Mexico and rest of South America. Due to increase in research activities on cell culture and government initiatives in funding the research on drug development are the driving the market growth in this region.
The key players in the mycoplasma testing market include Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
